250 related articles for article (PubMed ID: 33580106)
1. Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis.
Irvine AF; Waise S; Green EW; Stuart B; Thomas GJ
Sci Rep; 2021 Feb; 11(1):3727. PubMed ID: 33580106
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
[TBL] [Abstract][Full Text] [Related]
6. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
[TBL] [Abstract][Full Text] [Related]
7. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
[TBL] [Abstract][Full Text] [Related]
9. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
[TBL] [Abstract][Full Text] [Related]
13. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
PeerJ; 2024; 12():e16958. PubMed ID: 38410801
[TBL] [Abstract][Full Text] [Related]
14. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.
Hu H; Piotrowska Z; Hare PJ; Chen H; Mulvey HE; Mayfield A; Noeen S; Kattermann K; Greenberg M; Williams A; Riley AK; Wilson JJ; Mao YQ; Huang RP; Banwait MK; Ho J; Crowther GS; Hariri LP; Heist RS; Kodack DP; Pinello L; Shaw AT; Mino-Kenudson M; Hata AN; Sequist LV; Benes CH; Niederst MJ; Engelman JA
Cancer Cell; 2021 Nov; 39(11):1531-1547.e10. PubMed ID: 34624218
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B
Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
18. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling.
Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Alfaro C; Sanchez JC; Franco F; Calvo V; Romero A; Martin-Acosta P; Salas C; Garcia JM; Provencio M
Free Radic Biol Med; 2019 Jan; 130():163-173. PubMed ID: 30391585
[TBL] [Abstract][Full Text] [Related]
20. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
